IL54754A - Spirochroman(and-thiochroman)hydantoins and pharmaceutical compositions containing them - Google Patents

Spirochroman(and-thiochroman)hydantoins and pharmaceutical compositions containing them

Info

Publication number
IL54754A
IL54754A IL54754A IL5475478A IL54754A IL 54754 A IL54754 A IL 54754A IL 54754 A IL54754 A IL 54754A IL 5475478 A IL5475478 A IL 5475478A IL 54754 A IL54754 A IL 54754A
Authority
IL
Israel
Prior art keywords
spirochroman
thiochroman
hydantoins
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL54754A
Other languages
English (en)
Other versions
IL54754A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL54754A0 publication Critical patent/IL54754A0/xx
Publication of IL54754A publication Critical patent/IL54754A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
IL54754A 1977-05-23 1978-05-22 Spirochroman(and-thiochroman)hydantoins and pharmaceutical compositions containing them IL54754A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/799,586 US4130714A (en) 1977-05-23 1977-05-23 Hydantoin therapeutic agents

Publications (2)

Publication Number Publication Date
IL54754A0 IL54754A0 (en) 1978-07-31
IL54754A true IL54754A (en) 1982-04-30

Family

ID=25176274

Family Applications (1)

Application Number Title Priority Date Filing Date
IL54754A IL54754A (en) 1977-05-23 1978-05-22 Spirochroman(and-thiochroman)hydantoins and pharmaceutical compositions containing them

Country Status (37)

Country Link
US (1) US4130714A (de)
JP (1) JPS6035350B2 (de)
AR (1) AR219531A1 (de)
AT (1) AT357170B (de)
AU (1) AU499518B1 (de)
BE (1) BE867248A (de)
CA (1) CA1088073A (de)
CH (1) CH631455A5 (de)
CS (1) CS200550B2 (de)
DD (1) DD137107A5 (de)
DE (2) DE2821966C2 (de)
DK (1) DK147941C (de)
EG (1) EG13691A (de)
ES (1) ES470070A1 (de)
FI (1) FI62838C (de)
FR (1) FR2392024A1 (de)
GB (1) GB1572688A (de)
GR (1) GR68694B (de)
HK (1) HK53981A (de)
HU (1) HU177718B (de)
IE (1) IE47273B1 (de)
IL (1) IL54754A (de)
IN (1) IN147854B (de)
IT (1) IT1096306B (de)
KE (1) KE3168A (de)
LU (1) LU79685A1 (de)
MY (1) MY8200156A (de)
NL (1) NL7804158A (de)
NO (1) NO150206C (de)
NZ (1) NZ187334A (de)
PH (1) PH13828A (de)
PL (1) PL110460B1 (de)
PT (1) PT68071B (de)
SE (1) SE437375B (de)
SU (1) SU873885A3 (de)
YU (1) YU40829B (de)
ZA (1) ZA782919B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4210667A (en) * 1979-04-19 1980-07-01 Pfizer Inc. Pharmaceutical preparations containing coumarin carboxylic acid derivatives
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4419521A (en) * 1981-11-12 1983-12-06 Pfizer Inc. 6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins
JPS58124788A (ja) * 1982-01-20 1983-07-25 Eisai Co Ltd 光学活性ヒダントイン誘導体，その製造方法ならびにそれを含有する治療用薬剤
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4431828A (en) * 1982-11-10 1984-02-14 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil
US4528387A (en) * 1982-11-10 1985-07-09 Pfizer Inc. Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US5153211A (en) * 1983-09-14 1992-10-06 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
JPH06772B2 (ja) * 1984-07-09 1994-01-05 鐘淵化学工業株式会社 ３―（４―フルオロフエノキシ）プロピオニトリルを用いる６―フルオロ―４―クロマノンの製造法
US4680306A (en) * 1984-07-20 1987-07-14 Pfizer Inc. Sprio-imidazolones for treatment of diabetes complications
US4656169A (en) * 1984-08-14 1987-04-07 Pfizer Inc. Tetracyclic spiro-hydantoin aldose reductase inhibitors and compositions
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US4620019A (en) * 1984-08-23 1986-10-28 Pfizer Inc. S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
WO1986007353A1 (en) 1985-06-14 1986-12-18 Pfizer Inc. Intermediate in the production of an asymmetric hydantoin
JPS627654U (de) * 1985-06-26 1987-01-17
WO1987004344A1 (en) * 1986-01-17 1987-07-30 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
AU598366B2 (en) * 1987-03-20 1990-06-21 Alcon Laboratories, Inc. Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
WO1992000071A1 (en) * 1989-02-10 1992-01-09 Washington Research Foundation Immunoregulatory agents
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5236945A (en) * 1990-06-11 1993-08-17 Pfizer Inc. 1H-indazole-3-acetic acids as aldose reductase inhibitors
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
US5728704A (en) * 1992-09-28 1998-03-17 Pfizer Inc. Substituted pyridmidines for control of diabetic complications
US5521208A (en) * 1993-07-29 1996-05-28 Alcon Laboratories, Inc. Compositions and methods for the treatment of the metabolically impaired and for improved compliance
NZ516696A (en) * 1997-04-15 2003-08-29 Csir Pharmaceutical compositions having appetite suppressant activity
GB2396815B (en) * 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
AU2002215160A1 (en) 2000-11-30 2002-06-11 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
US8877717B2 (en) 2007-03-12 2014-11-04 Zadec Aps Anti-diabetic extract of rooibos
WO2008118844A1 (en) 2007-03-23 2008-10-02 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibitors
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
EP2654749B1 (de) 2010-12-23 2017-05-10 The Board of Regents of The University of Texas System Verfahren zur behandlung von copd
UA118035C2 (uk) * 2013-10-07 2018-11-12 Сінгента Партісіпейшнс Аг Гербіцидні сполуки

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
US4130714A (en) 1978-12-19
FI62838B (fi) 1982-11-30
BE867248A (fr) 1978-11-20
DK147941B (da) 1985-01-14
EG13691A (en) 1982-12-31
NZ187334A (en) 1984-04-27
NO150206C (no) 1984-09-05
SE7803626L (sv) 1978-11-24
PT68071A (en) 1978-06-01
IE781015L (en) 1978-11-23
FR2392024B1 (de) 1981-07-24
CA1088073A (en) 1980-10-21
DD137107A5 (de) 1979-08-15
FI781613A (fi) 1978-11-24
SE437375B (sv) 1985-02-25
HK53981A (en) 1981-11-13
YU40829B (en) 1986-06-30
CS200550B2 (en) 1980-09-15
PT68071B (en) 1979-10-26
DK226778A (da) 1978-11-24
IL54754A0 (en) 1978-07-31
YU116978A (en) 1983-02-28
JPS53144575A (en) 1978-12-15
LU79685A1 (fr) 1979-12-06
DE2858042C2 (de) 1983-11-24
AU499518B1 (en) 1979-04-26
IT7823672A0 (it) 1978-05-22
GR68694B (de) 1982-02-01
FI62838C (fi) 1983-03-10
FR2392024A1 (fr) 1978-12-22
PL110460B1 (en) 1980-07-31
SU873885A3 (ru) 1981-10-15
PL206826A1 (pl) 1979-04-23
AT357170B (de) 1980-06-25
IT1096306B (it) 1985-08-26
JPS6035350B2 (ja) 1985-08-14
GB1572688A (en) 1980-07-30
NL7804158A (nl) 1978-11-27
IN147854B (de) 1980-07-19
ATA365378A (de) 1979-11-15
CH631455A5 (fr) 1982-08-13
KE3168A (en) 1981-11-06
MY8200156A (en) 1982-12-31
NO781769L (no) 1978-11-24
PH13828A (en) 1980-10-07
DK147941C (da) 1985-08-26
DE2821966A1 (de) 1978-11-30
HU177718B (en) 1981-12-28
NO150206B (no) 1984-05-28
ZA782919B (en) 1979-06-27
ES470070A1 (es) 1979-01-01
AR219531A1 (es) 1980-08-29
IE47273B1 (en) 1984-02-08
DE2821966C2 (de) 1983-06-01

Similar Documents

Publication Publication Date Title
IL54754A (en) Spirochroman(and-thiochroman)hydantoins and pharmaceutical compositions containing them
DE2860546D1 (en) Nitroimidazoles and pharmaceutical compositions containing them as well as their preparation
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
PH14216A (en) Polyene compounds and pharmaceutical compositions
ZA781398B (en) Pharmaceutical compositions
MY8500996A (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
NZ188721A (en) Imidazolidines and pharmaceutical compositions
JPS5455568A (en) 11substituted imidazoles and pharmaceutical composition
NZ188170A (en) Propenylamines and pharmaceutical compositions
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
DE2861282D1 (en) Antibiotics and pharmaceutical compositions containing them
IL54967A0 (en) Novel peptides and pharmaceutical compositions containing them
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
GB2008403B (en) Pharmaceutical compositions
NZ186689A (en) Substituted bis-benzimidazolyl compounds and pharmaceutical compositions
NZ187401A (en) Pharmaceutical compositions containing erythromycin and mey-4-amino-5-chloro-benzamide
ZM1878A1 (en) Pharmaceutical compositions
IL54220A (en) Pharmaceutical compositions comprising trans-broparestrol
NZ186410A (en) Imidazole derivatives and pharmaceutical compositions
GB2008408B (en) Pharmaceutical compositions
NZ187337A (en) 5-phenyl-1h-3-benzazepines and pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
IL57882A0 (en) 2-thiophenecarboxamido-alkylmercaptans and pharmaceutical compositions containing them
IL61826A0 (en) Pharmaceutical compositions containing pyranoquinolinone derivatives

Legal Events

Date Code Title Description
RH Patent void